Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: Cancer patients who smoke are advised to quit smoking to reduce treatment complications and future cancer risk. This study's main objective was to evaluate the efficacy of a novel, presurgical cessation intervention in newly diagnosed cancer patients scheduled for surgical hospitalization. METHOD: We conducted a parallel-arm, randomized controlled trial comparing the efficacy of our hospital-based, tobacco cessation "best practices" treatment model (BP; cessation counseling and nicotine replacement therapy) with BP enhanced by a behavioral tapering regimen (scheduled reduced smoking; BP + SRS) administered by a handheld computer before hospitalization for surgery. Cessation outcomes were short (hospital admission and 3 months) and longer-term (6 months) biochemically verified smoking abstinence. We hypothesized that BP + SRS would be superior to BP alone. One hundred eighty-five smokers were enrolled. RESULTS: Overall, 7-day-point prevalence, confirmed abstinence rates at 6 months for BP alone (32%) and BP + SRS (32%) were high; however, no main effect of treatment was observed. Patients who were older and diagnosed with lung cancer were more likely to quit smoking. CONCLUSION: Compared to best practices for treating tobacco dependence, a presurgical, scheduled reduced smoking intervention did not improve abstinence rates among newly diagnosed cancer patients.reserved).

publication date

  • July 29, 2013

Research

keywords

  • Neoplasms
  • Preoperative Care
  • Smoking Cessation
  • Smoking Prevention

Identity

PubMed Central ID

  • PMC4116187

Scopus Document Identifier

  • 84903526552

Digital Object Identifier (DOI)

  • 10.1097/JTO.0b013e318288dc96

PubMed ID

  • 23895203

Additional Document Info

volume

  • 33

issue

  • 7